SCHEMBL7076016

SCHEMBL7076016

COC(=O)c1ccsc1-c1cccc(OCCCN(C)C)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.49
ALDH1A1 P00352 4/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
MAPT P10636 1/20 0.46
KMT2A Q03164 1/20 0.46
LMNA P02545 2/20 0.44
CHEK2 O96017 1/20 0.44
ESR1 P03372 1/20 0.43
ROCK2 O75116 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C9 P11712 1/20 0.43
ROCK1 Q13464 1/20 0.43
KDR P35968 2/20 0.43
CHEK1 O14757 1/20 0.43
MAOA P21397 1/20 0.42
MAOB P27338 1/20 0.42
LSS P48449 1/20 0.42
CHRNB2 P17787 1/20 0.41
CHRNA4 P43681 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7136554 0.97 ALDH1A1 (0.50) KDM4EALDH1A1SMN1; SMN2MAPTKMT2A
SCHEMBL7076583 0.94 KDM4E (0.48) KDM4EALDH1A1SMN1; SMN2MAPTKMT2A
SCHEMBL7076243 0.88 KDM4E (0.54) KDM4EALDH1A1SMN1; SMN2MAPTKMT2A
SCHEMBL1776033 0.87 KDM4E (0.53) KDM4EALDH1A1SMN1; SMN2MAPTKMT2A
SCHEMBL7130108 0.87 KDM4E (0.43) KDM4EALDH1A1MAPTKMT2ALMNA
SCHEMBL7075963 0.85 ALDH1A1 (0.55) KDM4EALDH1A1SMN1; SMN2MAPTKMT2A
SCHEMBL7074931 0.85 KDM4E (0.44) KDM4EALDH1A1MAPTKMT2ALMNA
SCHEMBL7075715 0.85 KDM4E (0.43) KDM4EALDH1A1MAPTKMT2ALMNA
SCHEMBL7076586 0.82 KDM4E (0.49) KDM4EALDH1A1SMN1; SMN2MAPTKDR
SCHEMBL7131687 0.82 KDM4E (0.53) KDM4EALDH1A1SMN1; SMN2MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003051368-A1 N-AROYL CYCLIC AMINE DERIVATIVES AS OREXIN RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 2003-06-26 WO disclosed